VECTIVBIO HLDG AG's ticker is VECT and the CUSIP is H9060V101. A total of 27 filers reported holding VECTIVBIO HLDG AG in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $46,945,093 | +5.0% | 2,782,756 | -47.1% | 14.24% | +20.0% |
| Q1 2023 | $44,724,170 | -6.0% | 5,255,484 | -4.3% | 11.87% | -6.3% |
| Q4 2022 | $47,595,916 | +92.6% | 5,492,893 | +33.3% | 12.68% | +90.7% |
| Q3 2022 | $24,717,000 | +21.0% | 4,119,572 | +8.9% | 6.65% | -14.8% |
| Q2 2022 | $20,424,000 | +40.6% | 3,782,199 | +22.6% | 7.80% | +26.3% |
| Q1 2022 | $14,527,000 | +10.6% | 3,084,310 | +15.3% | 6.18% | +41.7% |
| Q4 2021 | $13,136,000 | -34.4% | 2,675,408 | +3.2% | 4.36% | -25.4% |
| Q3 2021 | $20,028,000 | -33.6% | 2,592,602 | +0.3% | 5.85% | -16.7% |
| Q2 2021 | $30,152,000 | – | 2,585,986 | – | 7.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 3,084,310 | $14,527,000 | 6.18% |
| Novo Holdings A/S | 3,380,402 | $15,922,000 | 0.84% |
| Cormorant Asset Management, LP | 2,078,485 | $9,790,000 | 0.75% |
| Orbimed Advisors | 5,330,704 | $25,108,000 | 0.41% |
| Bpifrance SA | 2,806,217 | $13,217,000 | 0.37% |
| Eventide Asset Management | 2,339,044 | $10,994,000 | 0.17% |
| Tekla Capital Management LLC | 756,502 | $3,556,000 | 0.12% |
| Canaan Partners XI LLC | 37,051 | $175,000 | 0.07% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 393,365 | $1,849,000 | 0.02% |
| Citadel Advisors | 2,722,646 | $12,797,000 | 0.00% |